Literature DB >> 34603749

Designing spatial and temporal control of vaccine responses.

Gillie A Roth1, Vittoria C T M Picece2,3, Ben S Ou1, Wei Luo4, Bali Pulendran4,5,6,7,8, Eric A Appel1,2,5,9.   

Abstract

Vaccines are the key technology to combat existing and emerging infectious diseases. However, increasing the potency, quality and durability of the vaccine response remains a challenge. As our knowledge of the immune system deepens, it becomes clear that vaccine components must be in the right place at the right time to orchestrate a potent and durable response. Material platforms, such as nanoparticles, hydrogels and microneedles, can be engineered to spatially and temporally control the interactions of vaccine components with immune cells. Materials-based vaccination strategies can augment the immune response by improving innate immune cell activation, creating local inflammatory niches, targeting lymph node delivery and controlling the time frame of vaccine delivery, with the goal of inducing enhanced memory immunity to protect against future infections. In this Review, we highlight the biological mechanisms underlying strong humoral and cell-mediated immune responses and explore materials design strategies to manipulate and control these mechanisms. © Springer Nature Limited 2021.

Entities:  

Keywords:  Biomaterials - vaccines; Biomedical engineering; Chemical engineering; Vaccines

Year:  2021        PMID: 34603749      PMCID: PMC8477997          DOI: 10.1038/s41578-021-00372-2

Source DB:  PubMed          Journal:  Nat Rev Mater        ISSN: 2058-8437            Impact factor:   76.679


  257 in total

1.  Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

Authors:  Pamela A Kozlowski; Anna Aldovini
Journal:  Curr Immunol Rev       Date:  2019

2.  B Cells Are the Dominant Antigen-Presenting Cells that Activate Naive CD4+ T Cells upon Immunization with a Virus-Derived Nanoparticle Antigen.

Authors:  Sheng Hong; Zhimin Zhang; Hongtao Liu; Meijie Tian; Xiping Zhu; Zhuqiang Zhang; Weihong Wang; Xuyu Zhou; Fuping Zhang; Qing Ge; Bing Zhu; Hong Tang; Zhaolin Hua; Baidong Hou
Journal:  Immunity       Date:  2018-10-02       Impact factor: 31.745

Review 3.  Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.

Authors:  Mark R Prausnitz
Journal:  Annu Rev Chem Biomol Eng       Date:  2017-03-24       Impact factor: 11.059

4.  Novel vaccine delivery system induces robust humoral and cellular immune responses based on multiple mechanisms.

Authors:  Yue-Qi Wang; Jie Wu; Qing-Ze Fan; Meng Zhou; Zhan-Guo Yue; Guang-Hui Ma; Zhi-Guo Su
Journal:  Adv Healthc Mater       Date:  2013-11-06       Impact factor: 9.933

Review 5.  Microneedle-based vaccines.

Authors:  Mark R Prausnitz; John A Mikszta; Michel Cormier; Alexander K Andrianov
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

Review 6.  When designing vaccines, consider the starting material: the human B cell repertoire.

Authors:  Colin Havenar-Daughton; Robert K Abbott; William R Schief; Shane Crotty
Journal:  Curr Opin Immunol       Date:  2018-09-03       Impact factor: 7.486

Review 7.  Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells.

Authors:  Doan C Nguyen; Chester J Joyner; Iñaki Sanz; F Eun-Hyung Lee
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

8.  Considerations for Size, Surface Charge, Polymer Degradation, Co-Delivery, and Manufacturability in the Development of Polymeric Particle Vaccines for Infectious Diseases.

Authors:  Christopher J Genito; Cole J Batty; Eric M Bachelder; Kristy M Ainslie
Journal:  Adv Nanobiomed Res       Date:  2021-01-18

Review 9.  Vaccine Adjuvants: from 1920 to 2015 and Beyond.

Authors:  Alberta Di Pasquale; Scott Preiss; Fernanda Tavares Da Silva; Nathalie Garçon
Journal:  Vaccines (Basel)       Date:  2015-04-16

10.  Role of nanoscale antigen organization on B-cell activation probed using DNA origami.

Authors:  Rémi Veneziano; Tyson J Moyer; Matthew B Stone; Eike-Christian Wamhoff; Benjamin J Read; Sayak Mukherjee; Tyson R Shepherd; Jayajit Das; William R Schief; Darrell J Irvine; Mark Bathe
Journal:  Nat Nanotechnol       Date:  2020-06-29       Impact factor: 40.523

View more
  14 in total

1.  Injectable Liposome-based Supramolecular Hydrogels for the Programmable Release of Multiple Protein Drugs.

Authors:  Santiago Correa; Abigail K Grosskopf; John H Klich; Hector Lopez Hernandez; Eric A Appel
Journal:  Matter       Date:  2022-03-21

Review 2.  Self-Assembling Peptide-Based Hydrogels for Wound Tissue Repair.

Authors:  Tong Guan; Jiayang Li; Chunying Chen; Ying Liu
Journal:  Adv Sci (Weinh)       Date:  2022-02-09       Impact factor: 16.806

3.  BCG revaccination qualitatively and quantitatively enhances SARS-CoV-2 spike-specific neutralizing antibody and T cell responses induced by the COVISHIELDTM vaccine in SARS-CoV-2 seronegative young Indian adults.

Authors:  Srabanti Rakshit; Vasista Adiga; Asma Ahmed; Chaitra Parthiban; Nirutha Kumar; Sudarshan Shivalingaiah; Srishti Rao; George D'Souza; Pratibha Dwarkanath; Mary Dias; Thomas Maguire; Katie Doores; Prokar Dasgupta; Sudhir Babji; Tom Ottenhoff; Kenneth Stuart; Stephen De Rosa; M Juliana McElrath; Annapurna Vyakarnam
Journal:  Res Sq       Date:  2022-03-02

Review 4.  Methodological Approaches To Assess Innate Immunity and Innate Memory in Marine Invertebrates and Humans.

Authors:  Manon Auguste; Daniela Melillo; Annunziata Corteggio; Rita Marino; Laura Canesi; Annalisa Pinsino; Paola Italiani; Diana Boraschi
Journal:  Front Toxicol       Date:  2022-02-18

Review 5.  Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy.

Authors:  Shuyan Han; Jun Wu
Journal:  Bioact Mater       Date:  2022-01-26

6.  Combined Subcutaneous-Intranasal Immunization With Epitope-Based Antigens Elicits Binding and Neutralizing Antibody Responses in Serum and Mucosae Against PRRSV-2 and SARS-CoV-2.

Authors:  Mario Fragoso-Saavedra; Carmen Ramírez-Estudillo; Diana L Peláez-González; Jorge O Ramos-Flores; Gustavo Torres-Franco; Leandro Núñez-Muñoz; Gabriel Marcelino-Pérez; María G Segura-Covarrubias; Rogelio González-González; Roberto Ruiz-Medrano; Beatriz Xoconostle-Cázares; Amanda Gayosso-Vázquez; Silvia Reyes-Maya; Vianey Ramírez-Andoney; Rogelio A Alonso-Morales; Marco A Vega-López
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

Review 7.  Self-adjuvanting cancer nanovaccines.

Authors:  Zhiyun Liao; Jing Huang; Pui-Chi Lo; Jonathan F Lovell; Honglin Jin; Kunyu Yang
Journal:  J Nanobiotechnology       Date:  2022-07-26       Impact factor: 9.429

Review 8.  Protein-Based Adjuvants for Vaccines as Immunomodulators of the Innate and Adaptive Immune Response: Current Knowledge, Challenges, and Future Opportunities.

Authors:  Diego A Díaz-Dinamarca; Michelle L Salazar; Byron N Castillo; Augusto Manubens; Abel E Vasquez; Fabián Salazar; María Inés Becker
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

9.  Sequential acid/reduction response of triblock copolymeric nanomicelles to release camptothecin and toll-like receptor 7/8 agonist for orchestrated chemoimmunotherapy.

Authors:  Xiaoyan Ge; Yanyun Hao; Hui Li; Huajun Zhao; Yang Liu; Yutong Liu; Xia Li; Hongfei Chen; Jing Zou; Shiying Zhang; Lingling Huang; Gang Shan; Zhiyue Zhang
Journal:  J Nanobiotechnology       Date:  2022-08-11       Impact factor: 9.429

Review 10.  Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases.

Authors:  Hasnat Tariq; Sannia Batool; Saaim Asif; Mohammad Ali; Bilal Haider Abbasi
Journal:  Front Microbiol       Date:  2022-01-03       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.